Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cue Biopharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 47 | 52 | +5 |
| Shares | 17.4M | 18.1M | +707.2K (+4.1%) |
| Value | $11.9M | $13.0M | +$1.13M (+9.5%) |
New holders (9)
Institutions that held Cue Biopharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boothbay Fund Management, LLC | 610,964 | $439.1K | 0.01% |
| Squarepoint Ops LLC | 85,800 | $61.7K | 0.00% |
| Two Sigma Securities, LLC | 39,514 | $28.4K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,135 | $7.28K | 0.00% |
| Simplex Trading, LLC | 4,832 | $3.00K | 0.00% |
| Mather Group, LLC. | 1,000 | $719 | 0.00% |
| Advisory Services Network, LLC | 200 | $144 | 0.00% |
| Citigroup Inc | 132 | $95 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Cue Biopharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Salzhauer Michael | 16,000 | $10.9K |
| HRT Financial LP | 11,812 | $8.00K |
| Beacon Pointe Advisors, LLC | 10,000 | $6.82K |
| Raymond James Financial Inc | 3,350 | $2.29K |